NCT02208934
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- CIM-Sant Pau - IIB Sant Pau, HSCSP Barcelona, Spain
- Palobiofarma S.L. (molecule owner) Mataró, Barcelona, Spain
Clinical trial condition
Heredodegenerative Disorders, Nervous System
Explore clinical trials studying Heredodegenerative Disorders, Nervous System. Study availability and eligibility vary by location and protocol.
1,877 public trials
411 recruiting studies
Heredodegenerative Disorders, Nervous System trial results
NCT01664000
- Conditions
- Ataxia, Brain Diseases, Carcinoma, +17 more
- Locations
-
- Dana-Farber / Beth Israel Deaconess Medical Center / Harvard Cancer Center Boston, Massachusetts, United States
NCT02619084
- Conditions
- Anxiety Disorders, Basal Ganglia Diseases, Brain Diseases, +20 more
- Locations
-
- Fondazione IRCCS Istituto neurologico Carlo Besta Milan, Italy
NCT00858689
- Conditions
- Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
- Locations
-
- Surrey Place Centre Toronto, Ontario, Canada
NCT00789828
- Conditions
- Astrocytoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +21 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Barrow Tuberous Sclerosis Center Phoenix, Arizona, United States
- University of California at Los Angeles Los Angeles, California, United States
- Children's Hospital Oakland Hematology/Oncology Dept Oakland, California, United States
NCT02670694
- Conditions
- Abnormalities, Multiple, Angelman Syndrome, Central Nervous System Diseases, +24 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California, Irvine Medical Center Irvine, California, United States
- Rady Children's Hospital San Diego, California, United States
- University of Florida College of Medicine Gainesville, Florida, United States
Completed
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
NCT00589784
- Conditions
- Brain Diseases, Brain Neoplasms, CNS Cancer, +42 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT02256475
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
- Locations
-
- San Diego, California, United States
- Kissimmee, Florida, United States
- St. Petersburg, Florida, United States
- Naperville, Illinois, United States
NCT00218777
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +15 more
- Locations
-
- UCLA Child OCD, Anxiety, and Tic Disorders Program Los Angeles, California, United States
- Johns Hopkins University Baltimore, Maryland, United States
- University of Wisconsin-Milwaukee Milwaukee, Wisconsin, United States
NCT00989742
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +23 more
- Locations
-
- Nottingham University Hospitals Nottingham, United Kingdom